Design-augmented (DA) biologics: BMP chimeras for bone and cartilage regeneration

Osteoarthritis Cartilage. 2020 Feb;28(2):123-125. doi: 10.1016/j.joca.2019.09.004. Epub 2019 Oct 10.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Activins / genetics
  • Activins / pharmacology
  • Biological Products*
  • Bone Morphogenetic Protein 2 / genetics
  • Bone Morphogenetic Protein 2 / pharmacology
  • Bone Morphogenetic Protein 6 / genetics
  • Bone Morphogenetic Protein 6 / pharmacology
  • Bone Morphogenetic Protein 7 / genetics
  • Bone Morphogenetic Protein 7 / pharmacology
  • Bone Morphogenetic Proteins / genetics
  • Bone Morphogenetic Proteins / pharmacology
  • Bone Regeneration / drug effects*
  • Cartilage / drug effects*
  • Drug Design*
  • Humans
  • Recombinant Fusion Proteins / pharmacology*
  • Regeneration / drug effects

Substances

  • AB204
  • Biological Products
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Protein 6
  • Bone Morphogenetic Protein 7
  • Bone Morphogenetic Proteins
  • Recombinant Fusion Proteins
  • activin A
  • Activins